Pan-cancer expression analysis using GEPIA2, which integrates RNA-seq data from TCGA and GTEx, revealed that SMYD3 mRNA is widely expressed across solid tumors and notably upregulated in several malignancies, including colorectal cancer (CRC) (Figure 1A). This evidence concerns the gene SMYD3 and colorectal carcinoma.